Chicago Board of Education, Illinois; Tax Secured, General Obligation Dec 03

  • ID: 2033679
  • December 2003
  • Region: Illinois
  • Standard & Poors
1 of 3

The 'A+' rating on Chicago Board of Education, Ill.'s GO bonds (alternative revenue source) series 2003D reflects: Chicago's deep and diverse economic base, which has been shielded from a deep downturn during the current recession; Sound financial management and institutionalized practices, producing a long-term trend of solid operations; Successful management and absorption of a massive construction program, to date; and Continued constituent support for board policies and reform measures resulting from improving test scores, higher enrollment, attendance and graduation rates, and lower incidences of truancy--all of which enhance the likelihood of additional achievement. Mitigating factors include the following: Challenges related to identifying funding sources for a multibillion-dollar capital improvement program (CIP), made massive by the size of the system and...

Companies mentioned in this report are:
- Chicago Brd of Ed

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- Chicago Brd of Ed

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.